Bexagliflozin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Are SGLT2 inhibitors really associated with increased urinary tract infection risk? A trial-level meta-analysis across type 2 diabetes, heart failure, and chronic kidney disease.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Published: June 30, 2026
Comparison of effectiveness and safety of bexagliflozin and other sodium-glucose cotransporter 2 inhibitors for type 2 diabetes mellitus in adults: systematic review and network meta-analysis of randomized controlled trials.
Journal: Frontiers in endocrinology
Published: March 31, 2026
Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial.
Journal: Journal of the American Veterinary Medical Association
Published: February 06, 2026
Post-marketing safety monitoring of sodium-glucose cotransporter 2 inhibitors for diabetes in cats: a pharmacovigilance study based on the FDA ADAE database.
Journal: Journal of veterinary internal medicine
Published: February 05, 2026
Case Report: Bexagliflozin as an adjunct decongestive strategy in a cat with congestive heart failure and advanced chronic kidney disease.
Journal: Frontiers in veterinary science
Published: January 19, 2026
Pharmacokinetics of Bexagliflozin After Intravenous and Oral Administration in Cats.
Journal: Journal of veterinary pharmacology and therapeutics
Published: December 11, 2025
Noninsulin drugs for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025
Comparison chart: Sodium-glucose cotransporter 2 (SGLT2) inhibitors.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025
Clinical therapeutics in feline medicine: updates for old and new drugs.
Journal: Journal of feline medicine and surgery
Published: October 06, 2025
Cardiovascular outcomes of novel SGLT2 inhibitors in patients with type 2 diabetes: a network meta-analysis of bexagliflozin, ertugliflozin and sotagliflozin.
Journal: Diabetes research and clinical practice
Published: September 22, 2025
Comparative Effect of SGLT2 Inhibitors and GLP-1 Agonists on Glycemic Control in Type 2 Diabetes Mellitus.
Journal: Journal of pharmacy & bioallied sciences
Published: August 02, 2025
The Chemistry of Gliflozins: Recent Advancements in SGLT-2 Inhibitors.
Journal: Cardiovascular & hematological agents in medicinal chemistry
Published: July 26, 2025
Last Updated: 09/26/2026